Article Text

Download PDFPDF
Review
Applications and advances of CRISPR-Cas9 in cancer immunotherapy
  1. An-Liang Xia1,2,
  2. Qi-Feng He1,2,
  3. Jin-Cheng Wang1,2,
  4. Jing Zhu3,
  5. Ye-Qin Sha3,
  6. Beicheng Sun2,
  7. Xiao-Jie Lu1
  1. 1 Department of General Surgery, Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
  2. 2 Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
  3. 3 Nanjing Medical University, Nanjing, China
  1. Correspondence to Dr Xiao-Jie Lu, Department of General Surgery, Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210009, China; 189{at}whu.edu.cn

Footnotes

  • A-LX, Q-FH and J-CW contributed equally.

  • Contributors XJL conceived the idea. A-LX drafted the manuscript. Q-FH, J-CW, JZ and Y-QS contributed to performing the literature collection. BS and X-JL directed and approved the manuscript. All the authors gave the final approval of the manuscript submission.

  • Funding This work was supported by grants from the National Natural Science Foundation (grant number: 81772596 to X-JL).

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • A-LX, Q-FH and J-CW contributed equally.

  • Contributors XJL conceived the idea. A-LX drafted the manuscript. Q-FH, J-CW, JZ and Y-QS contributed to performing the literature collection. BS and X-JL directed and approved the manuscript. All the authors gave the final approval of the manuscript submission.

  • Funding This work was supported by grants from the National Natural Science Foundation (grant number: 81772596 to X-JL).

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.